Contact tracing, or meticulously tracing individuals exposed to illness, has been key to combating outbreaks of Ebola, cholera and tuberculosis throughout the world. Dr. Sheila Davis of the nonprofit Partners in Health explains what the US can learn from those crises.
Iran has the fifth highest death toll from COVID-19. And while some people are wondering whether they can survive financially, others are struggling to overcome the disease.
Hungary's government under Prime Minister Viktor Orbán has granted itself sweeping powers under the auspices of the coronavirus pandemic. But critics warn it is hastening Hungary's authoritarian decline.
Months of anti-government protests have eroded the popularity and legitimacy of Lebanon's traditional political parties. But the novel coronavirus has given them a chance to get it back by launching their own health and sanitation campaigns.
Monkeys at the Tulane National Primate Research Center have been infected with the coronavirus. Eventually, the animals will be tested with potential vaccines.
President Jair Bolsonaro has remained defiant even after US President Donald Trump, who has been his political role model, walked back his own skepticism about the coronavirus outbreak. Bolsonaro’s stance has isolated him politically in Brazil.
The US just passed a $2 trillion stimulus. But how does it look compared to efforts in some European countries to mitigate the economic effect of the coronavirus pandemic?
While an increasing number of countries are tightening their borders in an effort to halt further infections, South Korea is taking a different approach. But a rise in imported cases threatens to roll back some of the country’s progress.
Even before COVID-19 swept through the country, South Korea had a well-known reputation for being a so-called “delivery nation.”
When a treatment for the coronavirus becomes available, who would get access to it? This question is of growing concern to policymakers and medical officials around the globe. Dr. Manuel Martin, an advisor with Médecins Sans Frontières, speaks with The World's Marco Werman about why a potential monopoly by one pharmaceutical company worries him.